Evaluation of Implementation of the Phoenix PrEP (Pre-Exposure Prophylaxis) Access Project for Youth Aged 13-24

Exclusion Criteria

• •Unknown or Positive HIV status,
• •Renal Impairment as indicated by elevated BUN or Creatinine, abnormal urinalysis,
• •Active infection with Hepatitis B Virus,
• •Taking other medications containing Emtricitabine, Tenofovir or tenofovir alafenamide(TAF) such as Atripla, Complera, Emtriva, Genvoya, Odefsey, Stribild, and Viread taking drugs containing lamivudine,
• •taking Hepsera,
• •clinical symptoms consistent with acute viral infection within the past month.